A major mutation of KIF21A associated with congenital fibrosis of the extraocular muscles type 1 (CFEOM1) enhances translocation of Kank1 to the membrane

Biochemical and Biophysical Research Communications

Volumn 386, Issue 4, 2009, Pages 639-644

  Kakinuma, Naoto ^a   Kiyama, Ryoiti ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Actin polymerization; Cell mobility; Congenital fibrosis of the extraocular muscles type 1; Neuronal development; Translocation

Indexed keywords

ANKYRIN; HETERODIMER; KANK1 PROTEIN; KIF21A PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; EXTRAOCULAR MUSCLE; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; KIF21A GENE; MYOFIBROSIS; NERVE FIBER GROWTH; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; WILD TYPE;

ANKYRIN REPEAT; BLEPHAROPTOSIS; CELL MEMBRANE; FIBROSIS; HELA CELLS; HUMANS; KINESIN; MUTATION; OCULOMOTOR MUSCLES; OPHTHALMOPLEGIA; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; TUMOR SUPPRESSOR PROTEINS;

EID: 67650494721     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.109     Document Type: Article

References (16)

1. Engle E.C., Goumnerov B.C., Mckeown C.A., Schatz M., Johns D.R., Porter J.D., and Beggs A.H. Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles. Ann. Neurol. 41 (1997) 314-325
2. Yamada K., Andrews C., Chan W.M., McKeown C.A., Magli A., de Berardinis T., Loewenstein A., Lazar M., O'Keefe M., Letson R., London A., Ruttum M., Matsumoto N., Saito N., Morris L., Del Monte M., Johnson R.H., Uyama E., Houtman W.A., de Vries B., Carlow T.J., Hart B.L., Krawiecki N., Shoffner J., Vogel M.C., Katowitz J., Goldstein S.M., Levin A.V., Sener E.C., Ozturk B.T., Akarsu A.N., Brodsky M.C., Manisch F., Cruse R.P., Zubcov A.A., Robb R.M., Roggenkäemper P., Gpttlob I., Kowal L., Battu R., Traboulsi E.I., Franceschini P., Newlin A., Demer J.L., and Engle E.C. Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). Nat. Genet. 35 (2003) 318-321
3. Yamada K., Chan W.M., Andrews C., Bosley T.M., Sener E.C., Zwaan J.T., Mullaney P.B., Öztrürk B.T., Akarsu A.N., Sabol L.J., Demer J.L., Sullivan T.J., Gottlob I., Roggenkäemper P., Mackey D.A., De Uzcategui C.E., Ben-Zeev B., Traboulsi E.I., Magli A., de Berardinis T., Gagliardi V., Awasthi-Patney S., Vogel M.C., Rizzo III J.F., and Engle E.C. Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3). Invest. Ophthalmol. Vis. Sci. 45 (2004) 2218-2223
4. Shimizu S., Okinaga A., and Maruo T. Recurrent mutation of the KIF21A gene in Japanese patients with congenital fibrosis of the extraocular muscles. Jpn. J. Ophthalmol. 49 (2005) 443-447
5. Yamada K., Hunter D.G., Andrews C., and Engle E.C. A novel KIF21A mutation in a patient with congenital fibrosis of the extraocular muscles and Marcus Gunn jaw-winking phenomenon. Arch. Ophthalmol. 123 (2005) 1254-1259
6. Chan W.M., Andrews C., Dragan L., Fredrick D., Armstrong L., Lyons C., Geraghty M.T., Hunter D.G., Yazdani A., Traboulsi E.I., Pott J.W., Gutowski N.J., Ellard S., Young E., Hanisch F., Koc F., Schnall B., and Engle E.C. Three novel mutations in KIF21A highlight the importance of the third coiled-coil stalk domain in the etiology of CFEOM1. BMC Genet. 8 (2007) 26
7. Khan A.O., Khalil D.S., and Al-Tassan N.A. Congenital fibrosis of the extraocular muscles type 1 (CFEOM1) on the Arabian Peninsula. Opthalmic. Genet. 29 (2008) 25-28
8. Lu S., Zhao C., Zhao K., Li N., and Larsson C. Novel and recurrent KIF21A mutations in congenital fibrosis of the extraocular muscles type 1 and 3. Arch. Ophthalmol. 126 (2008) 388-394
9. Marszalek J.R., Weiner J.A., Farlow S.J., and Chun J. Novel dendritic kinesin sorting identified by different process targeting of two related kinesins: KIF21A and KIF21B. J. Cell Biol. 145 (1999) 469-479
10. Shen X., Meza-Carmen V., Puxeddu E., Wang G., Moss J., and Vaughan M. Interaction of brefeldin A-inhibited guanine nucleotide exchange protein (BIG) 1 and kinesin motor protein KIF21A. Proc. Natl. Acad. Sci. USA 105 (2008) 18788-18793
11. Sarker S., Roy B.C., Hatano N., Aoyagi T., Gohji K., and Kiyama R. A novel ankyrin repeat-containing gene (Kank) located at 9p24 is a growth suppressor of renal cell carcinoma. J. Biol. Chem. 277 (2002) 36585-36591
12. Kakinuma N., Roy B.C., Zhu Y., Wong Y., and Kiyama R. Kank regulates RhoA-dependent formation of actin stress fibers and cell migration via 14-3-3 in PI3K-Akt signaling. J. Cell Biol. 181 (2008) 537-549
13. Roy B.C., Kakinuma N., and Kiyama R. Kank attenuates actin remodeling by preventing interaction between IRSp53 and Rac1. J. Cell Biol. 184 (2009) 253-267
14. Finn R.D., Tate J., Mistry J., Coggill P.C., Sammut S.J., Hotz H.R., Ceric G., Forslund K., Eddy S.R., Sonnhammer E.L., and Bateman A. The Pfam protein families database. Nucleic Acids Res. Database Issue 36 (2008) D281-D288
15. Delorenzi M., and Speed T. An HMM model for coiled-coil domains and a comparison with PSSM-based predictions. Bioinformatics 18 (2002) 617-625
16. Ding M., Goncharov A., Jin Y., and Chisholm A.D. C. elegans ankyrin repeat protein VAB-19 is a component of epidermal attachment structures and is essential for epidermal morphogenesis. Development 130 (2003) 5791-5801